Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are an adult who has recently been diagnosed with a type of blood cancer called AML (acute myeloid leukemia) that tests positive for a protein called "CD33," and your doctor has decided to treat you with a medication called Mylotarg® as part of your normal care, or has already started you on it
- You (or your legal representative) have read, understood, and signed a consent form agreeing to take part in the study
Who may not be able to join:
- You cannot take part if Mylotarg® is not medically suitable for you — for example, if you have ever had a severe allergic reaction (including anaphylaxis) to Mylotarg® or any of its ingredients
- You cannot take part if you (or your legal representative) do not agree to allow Pfizer and its partners to use your personal information for this study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pfizer CT.gov Call Center, Pfizer
Phone: 1-800-718-1021
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants With Treatment-Emergent Adverse Events (AEs), Serious Adverse Events (SAEs) and Adverse Events of Special Interest (AESI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.